Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microderm Technologies
Hong Kong, Hong Kong
- Ownership
- Private
- Development stage
- Other
01
Overview
Microderm Technologies launched Dermodacyn, a wound healing product based on Microcyn Technology, supported by clinical studies and internationally recognized. The product is available over-the-counter in Hong Kong for human use and aims to make first-class wound healing products accessible and affordable[1][3].
- Therapeutic areas
- Infectious DiseasesDermatology
- Modalities
- Device
- Industry
- Consumable Medical Devices
02
Partnerships
Sonoma Pharmaceuticals
Beyond the preview
Go deeper on Microderm Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Microderm Technologies.